Lau Yee Cheng, Xiong Qinmei, Blann Andrew D, Lip Gregory Y H
University of Birmingham Institute of Cardiovascular Science, City Hospital, Dudley Road, Birmingham, UK.
Cardiovascular Department, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
J Thromb Thrombolysis. 2017 Jan;43(1):18-23. doi: 10.1007/s11239-016-1427-3.
Atrial fibrillation (AF) and chronic kidney disease are closely related, and any associated risk of stroke and thromboembolism due to AF is increased by concurrent renal dysfunction. The mechanism(s) for this include abnormalities in platelets and endothelial cells. We hypothesized relationships between levels of circulating platelet microparticles (PMPs, defined by CD42b), soluble P selectin (both reflecting platelet activation), soluble E-selectin (reflecting endothelial activation) and endothelial/platelet microparticles (EPMPs, defined by CD31) with progressive renal dysfunction. Blood samples were obtained from 160 anticoagulated AF patients. Microparticles were measured by flow cytometry, soluble E and P selectin levels by ELISA. Renal function was determined by estimated glomerular filtration rate (eGFR). EPMP levels demonstrated a linear increased trend across quartiles of eGFR (p = 0.034) and CKD stage (p < 0.001), and correlated with eGFR and serum creatinine (p < 0.01). PMPs, P-selectin and E-selectin levels were not significantly different across groupings of renal dysfunction, and no significant correlations with eGFR were evident (p = 0.186, p = 0.561, p = 0.746 respectively). Stepwise multivariable regression analysis demonstrated that worsening renal function was an independent predictor of EPMP levels (p < 0.001). In well-anticoagulated AF patients, there is potential relationship between endothelial function (as judged by elevated EPMP levels, with no change in PMPs) and renal function. Other markers of prothombotic state or cellular activation (PMP, P-selectin and E-selectin levels) were not significantly different across the various degree of renal dysfunction. Renal function must be addressed when measuring EPMP levels.
心房颤动(AF)与慢性肾脏病密切相关,同时存在的肾功能不全可增加AF所致的任何相关卒中及血栓栓塞风险。其机制包括血小板和内皮细胞异常。我们推测循环血小板微粒(PMPs,由CD42b定义)、可溶性P选择素(两者均反映血小板活化)、可溶性E选择素(反映内皮细胞活化)及内皮/血小板微粒(EPMPs,由CD31定义)水平与肾功能进行性损害之间存在关联。采集了160例接受抗凝治疗的AF患者的血样。通过流式细胞术检测微粒,采用酶联免疫吸附测定法检测可溶性E选择素和P选择素水平。通过估算的肾小球滤过率(eGFR)来评估肾功能。EPMP水平在eGFR四分位数组(p = 0.034)和慢性肾脏病分期组(p < 0.001)中呈线性上升趋势,且与eGFR和血清肌酐相关(p < 0.01)。在肾功能不全分组中,PMPs、P选择素和E选择素水平无显著差异,且与eGFR无明显相关性(分别为p = 0.18, p = 0.561, p = 0.746)。逐步多变量回归分析表明,肾功能恶化是EPMP水平的独立预测因素(p < 0.001)。在抗凝良好的AF患者中,内皮功能(以升高的EPMP水平判断,PMPs无变化)与肾功能之间存在潜在关联。在不同程度的肾功能不全中,其他血栓前状态或细胞活化标志物(PMP、P选择素和E选择素水平)无显著差异。在检测EPMP水平时必须考虑肾功能。